These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 9730300)
41. Mycobacterium genavense infections: a retrospective multicenter study in France, 1996-2007. Charles P; Lortholary O; Dechartres A; Doustdar F; Viard JP; Lecuit M; Gutierrez MC; Medicine (Baltimore); 2011 Jul; 90(4):223-230. PubMed ID: 21694645 [TBL] [Abstract][Full Text] [Related]
42. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083 [TBL] [Abstract][Full Text] [Related]
43. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764 [TBL] [Abstract][Full Text] [Related]
44. Correlation of quantitative bone marrow and blood cultures in AIDS patients with disseminated Mycobacterium avium complex infection. Hafner R; Inderlied CB; Peterson DM; Wright DJ; Standiford HC; Drusano G; Muth K J Infect Dis; 1999 Aug; 180(2):438-47. PubMed ID: 10395860 [TBL] [Abstract][Full Text] [Related]
45. Clinical and epidemiologic features of infection with Mycobacterium genavense. Swiss HIV Cohort Study. Pechère M; Opravil M; Wald A; Chave JP; Bessesen M; Sievers A; Hein R; von Overbeck J; Clark RA; Tortoli E Arch Intern Med; 1995 Feb; 155(4):400-4. PubMed ID: 7848023 [TBL] [Abstract][Full Text] [Related]
46. [Treatment with clarithromycin of 173 HIV+ patients with disseminated Mycobacterium avium intracellulare infection]. Dautzenberg B; Saint-Marc T; Durant J; Reynes J; Meyohas MC; Legrand MF; Truffot C; Chauvin JP Rev Mal Respir; 1994; 11(3):271-6. PubMed ID: 8041990 [TBL] [Abstract][Full Text] [Related]
47. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. Shafran SD; Deschênes J; Miller M; Phillips P; Toma E N Engl J Med; 1994 Feb; 330(6):438-9. PubMed ID: 8284019 [No Abstract] [Full Text] [Related]
48. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome. Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880 [TBL] [Abstract][Full Text] [Related]
49. Mycobacterium genavense infection presenting as a solitary brain mass in a patient with AIDS: case report and review. Berman SM; Kim RC; Haghighat D; Mulligan ME; Fierer J; Wyle FC Clin Infect Dis; 1994 Dec; 19(6):1152-4. PubMed ID: 7888551 [TBL] [Abstract][Full Text] [Related]
51. Clinical isolates of Mycobacterium simiae in San Antonio, Texas. An 11-yr review. Valero G; Peters J; Jorgensen JH; Graybill JR Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1555-7. PubMed ID: 7582293 [TBL] [Abstract][Full Text] [Related]
52. SAPHO syndrome-like presentation of disseminated nontuberculous mycobacterial infection in a case with neutralizing anti-IFNγ autoantibody. Furuya H; Ikeda K; Miyachi K; Nakamura K; Suzuki K; Furuta S; Tamachi T; Hirose K; Sakagami T; Nakajima H Rheumatology (Oxford); 2017 Jul; 56(7):1241-1243. PubMed ID: 28371927 [No Abstract] [Full Text] [Related]
53. Impact of clarithromycin and azithromycin on patterns of treatment and survival among AIDS patients with disseminated Mycobacterium avium complex. Ives DV; Davis RB; Currier JS AIDS; 1995 Mar; 9(3):261-6. PubMed ID: 7755914 [TBL] [Abstract][Full Text] [Related]
54. [Mycobacterium malmoense infection in an immunocompetent patient]. Guiot J; Ramaut M; Massart B; Louis R Rev Med Liege; 2009; 64(7-8):390-3. PubMed ID: 19777918 [TBL] [Abstract][Full Text] [Related]
55. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. van Ingen J; Totten SE; Heifets LB; Boeree MJ; Daley CL Int J Antimicrob Agents; 2012 Feb; 39(2):173-6. PubMed ID: 22099521 [TBL] [Abstract][Full Text] [Related]
56. Long-term outcomes of treatment of Mycobacterium avium complex bacteremia using a clarithromycin-containing regimen. Burman WJ; Stone BL; Rietmeijer CA; Maslow J; Cohn DL; Reves RR AIDS; 1998 Jul; 12(11):1309-15. PubMed ID: 9708410 [TBL] [Abstract][Full Text] [Related]
58. How to treat bacteraemic Mycobacterium avium complex disease. Chin DP; Hopewell PC Lancet; 1995 Oct; 346(8980):920-1. PubMed ID: 7564723 [No Abstract] [Full Text] [Related]
59. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin. Zahid MA; Klotz SA; Goldstein E; Bartholomew W Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568 [TBL] [Abstract][Full Text] [Related]
60. Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection. Jacobson MA; Yajko D; Northfelt D; Charlebois E; Gary D; Brosgart C; Sanders CA; Hadley WK J Infect Dis; 1993 Jul; 168(1):112-9. PubMed ID: 8515098 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]